Annual EBITDA:
-$212.63M+$125.58M(+37.13%)Summary
- As of today, TVTX annual EBITDA is -$212.63 million, with the most recent change of +$125.58 million (+37.13%) on December 31, 2024.
- During the last 3 years, TVTX annual EBITDA has fallen by -$99.74 million (-88.35%).
- TVTX annual EBITDA is now -30375471.43% below its all-time high of -$700.00, reached on February 28, 2011.
Performance
TVTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$1.37M+$31.24M(+104.57%)Summary
- As of today, TVTX quarterly EBITDA is $1.37 million, with the most recent change of +$31.24 million (+104.57%) on June 30, 2025.
- Over the past year, TVTX quarterly EBITDA has increased by +$58.07 million (+102.41%).
- TVTX quarterly EBITDA is now at all-time high.
Performance
TVTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$120.53M+$58.07M(+32.51%)Summary
- As of today, TVTX TTM EBITDA is -$120.53 million, with the most recent change of +$58.07 million (+32.51%) on June 30, 2025.
- Over the past year, TVTX TTM EBITDA has increased by +$152.16 million (+55.80%).
- TVTX TTM EBITDA is now -30133400.00% below its all-time high of -$400.00, reached on May 1, 2008.
Performance
TVTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TVTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +37.1% | +102.4% | +55.8% |
| 3Y3 Years | -88.3% | +102.6% | +21.8% |
| 5Y5 Years | -167.8% | +110.5% | -162.8% |
TVTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -88.3% | +37.1% | at high | +101.6% | at high | +61.5% |
| 5Y | 5-Year | -328.8% | +37.1% | at high | +101.6% | -162.8% | +61.5% |
| All-Time | All-Time | >-9999.0% | +37.1% | at high | +101.6% | >-9999.0% | +61.5% |
TVTX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.37M(+104.6%) | -$120.53M(+32.5%) |
| Mar 2025 | - | -$29.87M(+36.8%) | -$178.61M(+16.0%) |
| Dec 2024 | -$212.63M(+37.1%) | -$47.24M(-5.5%) | -$212.63M(+10.0%) |
| Sep 2024 | - | -$44.79M(+21.0%) | -$236.37M(+13.3%) |
| Jun 2024 | - | -$56.71M(+11.2%) | -$272.70M(+5.3%) |
| Mar 2024 | - | -$63.89M(+10.0%) | -$287.83M(+6.3%) |
| Dec 2023 | -$338.21M(-13.1%) | -$70.99M(+12.5%) | -$307.08M(+2.0%) |
| Sep 2023 | - | -$81.11M(-12.9%) | -$313.50M(-1.5%) |
| Jun 2023 | - | -$71.84M(+13.6%) | -$308.84M(-6.7%) |
| Mar 2023 | - | -$83.15M(-7.4%) | -$289.44M(-13.0%) |
| Dec 2022 | -$299.09M(-164.9%) | -$77.40M(-1.2%) | -$256.25M(-16.1%) |
| Sep 2022 | - | -$76.45M(-45.8%) | -$220.68M(-43.1%) |
| Jun 2022 | - | -$52.44M(-5.0%) | -$154.20M(-19.6%) |
| Mar 2022 | - | -$49.96M(-19.4%) | -$128.95M(-15.3%) |
| Dec 2021 | -$112.89M(-127.6%) | -$41.83M(-319.4%) | -$111.88M(-26.2%) |
| Sep 2021 | - | -$9.97M(+63.3%) | -$88.63M(-2.4%) |
| Jun 2021 | - | -$27.19M(+17.3%) | -$86.56M(-19.6%) |
| Mar 2021 | - | -$32.89M(-77.0%) | -$72.35M(-42.4%) |
| Dec 2020 | -$49.59M(+37.5%) | -$18.58M(-134.9%) | -$50.80M(-10.8%) |
| Sep 2020 | - | -$7.91M(+39.0%) | -$45.86M(+13.0%) |
| Jun 2020 | - | -$12.97M(-14.5%) | -$52.72M(+22.6%) |
| Mar 2020 | - | -$11.33M(+17.0%) | -$68.08M(+14.3%) |
| Dec 2019 | -$79.40M(-58.7%) | -$13.65M(+7.6%) | -$79.40M(-3.6%) |
| Sep 2019 | - | -$14.76M(+47.9%) | -$76.66M(-0.8%) |
| Jun 2019 | - | -$28.34M(-25.1%) | -$76.08M(-21.7%) |
| Mar 2019 | - | -$22.66M(-107.8%) | -$62.50M(-25.6%) |
| Dec 2018 | -$50.02M(-382.6%) | -$10.90M(+23.1%) | -$49.78M(-25.6%) |
| Sep 2018 | - | -$14.18M(+3.9%) | -$39.63M(-53.1%) |
| Jun 2018 | - | -$14.76M(-48.5%) | -$25.88M(-52.2%) |
| Mar 2018 | - | -$9.94M(-1216.2%) | -$17.00M(-22.8%) |
| Dec 2017 | -$10.37M | -$755.00K(-74.8%) | -$13.84M(+29.0%) |
| Sep 2017 | - | -$432.00K(+92.6%) | -$19.49M(+21.6%) |
| Jun 2017 | - | -$5.88M(+13.3%) | -$24.86M(-5.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$6.78M(-6.0%) | -$23.61M(-27.7%) |
| Dec 2016 | -$18.48M(+2.0%) | -$6.40M(-10.1%) | -$18.48M(-11.6%) |
| Sep 2016 | - | -$5.81M(-25.7%) | -$16.56M(-5.1%) |
| Jun 2016 | - | -$4.62M(-179.3%) | -$15.76M(-11.3%) |
| Mar 2016 | - | -$1.66M(+63.0%) | -$14.15M(+24.8%) |
| Dec 2015 | -$18.87M(+74.6%) | -$4.47M(+10.6%) | -$18.82M(+39.6%) |
| Sep 2015 | - | -$5.00M(-65.9%) | -$31.19M(+34.7%) |
| Jun 2015 | - | -$3.02M(+52.3%) | -$47.77M(+25.0%) |
| Mar 2015 | - | -$6.33M(+62.4%) | -$63.70M(+13.8%) |
| Dec 2014 | -$74.41M(-203.0%) | -$16.84M(+22.0%) | -$73.89M(-7.3%) |
| Sep 2014 | - | -$21.59M(-14.0%) | -$68.87M(-32.2%) |
| Jun 2014 | - | -$18.94M(-14.6%) | -$52.08M(-45.1%) |
| Mar 2014 | - | -$16.52M(-39.9%) | -$35.90M(-66.4%) |
| Dec 2013 | -$24.56M(+18.5%) | -$11.82M(-146.1%) | -$21.58M(+45.9%) |
| Sep 2013 | - | -$4.80M(-73.8%) | -$39.88M(-13.7%) |
| Jun 2013 | - | -$2.76M(-25.7%) | -$35.08M(-8.5%) |
| Mar 2013 | - | -$2.20M(+92.7%) | -$32.32M(-7.3%) |
| Dec 2012 | -$30.13M(>-9900.0%) | -$30.12M(>-9900.0%) | -$30.12M(>-9900.0%) |
| Nov 2011 | - | $0.00(0.0%) | -$600.00(+14.3%) |
| Aug 2011 | - | $0.00(0.0%) | -$700.00(0.0%) |
| May 2011 | - | $0.00(+100.0%) | -$700.00(0.0%) |
| Feb 2011 | -$700.00(+53.3%) | -$600.00(-500.0%) | -$700.00(-40.0%) |
| Nov 2010 | - | -$100.00(>-9900.0%) | -$500.00(-25.0%) |
| Aug 2010 | - | $0.00(0.0%) | -$400.00(+20.0%) |
| May 2010 | - | $0.00(+100.0%) | -$500.00(+66.7%) |
| Feb 2010 | -$1500.00(-7.1%) | -$400.00(>-9900.0%) | -$1500.00(-66.7%) |
| Nov 2009 | - | $0.00(+100.0%) | -$900.00(+57.1%) |
| Aug 2009 | - | -$100.00(+90.0%) | -$2100.00(-5.0%) |
| May 2009 | - | -$1000.00(-600.0%) | -$2000.00(-42.9%) |
| Feb 2009 | -$1400.00(+97.3%) | $200.00(+116.7%) | -$1400.00(+12.5%) |
| Nov 2008 | - | -$1200.00(>-9900.0%) | -$1600.00(-300.0%) |
| Aug 2008 | - | $0.00(+100.0%) | -$400.00(0.0%) |
| May 2008 | - | -$400.00 | -$400.00 |
| Feb 2008 | -$52.00K | - | - |
FAQ
- What is Travere Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Travere Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Travere Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Travere Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of TVTX is -$212.63M
What is the all-time high annual EBITDA for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high annual EBITDA is -$700.00
What is Travere Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, TVTX annual EBITDA has changed by +$125.58M (+37.13%)
What is Travere Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of TVTX is $1.37M
What is the all-time high quarterly EBITDA for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high quarterly EBITDA is $1.37M
What is Travere Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, TVTX quarterly EBITDA has changed by +$58.07M (+102.41%)
What is Travere Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of TVTX is -$120.53M
What is the all-time high TTM EBITDA for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high TTM EBITDA is -$400.00
What is Travere Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, TVTX TTM EBITDA has changed by +$152.16M (+55.80%)